0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Near-field detection and peak frequency metric for substrate and activation mapping of ventricular tachycardias in two- and three-dimensional circuits

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          Successful ventricular arrhythmia (VA) ablation requires identification of functionally critical sites during contact mapping. Estimation of the peak frequency (PF) component of the electrogram (EGM) may improve correct near-field (NF) annotation to identify circuit segments on the mapped surface. In turn, assessment of NF and far-field (FF) EGMs may delineate the three-dimensional path of a ventricular tachycardia (VT) circuit.

          Methods and results

          A proprietary NF detection algorithm was applied retrospectively to scar-related re-entry VT maps and compared with manually reviewed maps employing first deflection (FD corr) for VT activation maps and last deflection (LD) for substrate maps. Ventricular tachycardia isthmus location and characteristics mapped with FD corr vs. NF were compared. Omnipolar low-voltage areas, late activating areas, and deceleration zones (DZ) in LD vs. NF substrate maps were compared. On substrate maps, PF estimation was compared between isthmus and bystander sites. Activation mapping with entrainment and/or VT termination with radiofrequency (RF) ablation confirmed critical sites. Eighteen patients with high-density VT activation and substrate maps (55.6% ischaemic) were included. Near-field detection correctly located critical parts of the circuit in 77.7% of the cases compared with manually reviewed VT maps as reference. In substrate maps, NF detection identified deceleration zones in 88.8% of cases, which overlapped with FD corr VT isthmus in 72.2% compared with 83.3% overlap of DZ assessed by LD. Applied to substrate maps, PF as a stand-alone feature did not differentiate VT isthmus sites from low-voltage bystander sites. Omnipolar voltage was significantly higher at isthmus sites with longer EGM durations compared with low-voltage bystander sites.

          Conclusion

          The NF algorithm may enable rapid high-density activation mapping of VT circuits in the NF of the mapped surface. Integrated assessment and combined analysis of NF and FF EGM-components could support characterization of three-dimensional VT circuits with intramural segments. For scar-related substrate mapping, PF as a stand-alone EGM feature did not enable the differentiation of functionally critical sites of the dominant VT from low-voltage bystander sites in this cohort.

          Graphical Abstract

          Graphical Abstract

          Left top: LAT emphasis maps in VT activation mapping—Exemplary VT LAT maps with LAT-on-LAT emphasis in a RV VT and LV VT to highlight diastolic potentials. Left bottom: Example of left ventricular substrate map in a patient with extensive chronic anterior myocardial infarct (left, grey < 0.1 mV, purple > 1.5 mV) with emphasis on high-frequency EGMs (middle, emphasizing EGMs with >250 Hz) and visualization of peak frequency values (right, with nominal thresholds of EnSite X: grey < 200 Hz, white > 250 Hz). Right: Schematic illustration of how integration of NF and FF information may allow to distinguish two- and three-dimensional VT circuits and estimate the three-dimensional path of the VT CC. Yet, important confounders for using NF and peak frequency in ventricular mapping exist and need to be considered. 2D, two-dimensional; 3D, three-dimensional; EGM, electrogram; ICM, ischaemic cardiomyopathy; FF, far field; LV, left ventricle; NF, near field; RV, right ventricle; VT, ventricular tachycardia.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia.

          Catheter ablation of ventricular tachycardia (VT) is effective and particularly useful in patients with frequent defibrillator interventions. Various substrate modification techniques have been described for unmappable or hemodynamically intolerable VT. Noninducibility is the most frequently used end point but is associated with significant limitations, so the optimal end point remains unclear. We hypothesized that elimination of local abnormal ventricular activities (LAVAs) during sinus rhythm or ventricular pacing would be a useful and effective end point for substrate-based VT ablation. As an adjunct to this strategy, we used a new high-density mapping catheter and frequently used epicardial mapping.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Targeted Ablation of Ventricular Tachycardia Guided by Wavefront Discontinuities During Sinus Rhythm: A New Functional Substrate Mapping Strategy

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Decrement Evoked Potential Mapping: Basis of a Mechanistic Strategy for Ventricular Tachycardia Ablation.

              Substrate-based mapping for ventricular tachycardia (VT) ablation is hampered by its inability to determine critical sites of the VT circuit. We hypothesized that those potentials, which delay with a decremental extrastimulus (decrement evoked potentials or DEEPs), are more likely to colocalize with the diastolic pathways of VT circuits.
                Bookmark

                Author and article information

                Contributors
                Journal
                Europace
                Europace
                europace
                Europace
                Oxford University Press (UK )
                1099-5129
                1532-2092
                July 2024
                04 June 2024
                04 June 2024
                : 26
                : 7
                : euae154
                Affiliations
                Institute for Cardiovascular Science, University College London , 5 University Street, London, WC1E 6JF, UK
                Barts Heart Centre, St Bartholomew s Hospital , W Smithfield, London EC1A 7BE, UK
                Department of Cardiology, Hospital Universitario Ramón Y Cajal , Colmenar Viejo road, km. 9,100, Madrid 28034, Spain
                Department of Cardiology, Hospital Universitario Ramón Y Cajal , Colmenar Viejo road, km. 9,100, Madrid 28034, Spain
                Barts Heart Centre, St Bartholomew s Hospital , W Smithfield, London EC1A 7BE, UK
                Barts Heart Centre, St Bartholomew s Hospital , W Smithfield, London EC1A 7BE, UK
                Institute for Cardiovascular Science, University College London , 5 University Street, London, WC1E 6JF, UK
                Barts Heart Centre, St Bartholomew s Hospital , W Smithfield, London EC1A 7BE, UK
                Author notes
                Corresponding author.Tel: (+44) 020 7679 2000, E-mail address: johanna.tonko.21@ 123456ucl.ac.uk

                Conflict of interest: P.D.L. is supported by UCL/UCLH NIHR and Barts BRC. J.M. received speaker honoraria from Abbott Laboratories, Biosense Webster (J&J), and Boston Scientific. All remaining authors have declared no conflicts of interest.

                Author information
                https://orcid.org/0000-0002-4689-8384
                https://orcid.org/0000-0002-2303-9755
                https://orcid.org/0000-0001-5075-0684
                https://orcid.org/0000-0002-6111-0022
                https://orcid.org/0000-0002-9148-9571
                https://orcid.org/0000-0002-9055-9267
                Article
                euae154
                10.1093/europace/euae154
                11259853
                38833626
                06804b13-586a-473d-bc65-28820c70f67c
                © The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

                History
                : 12 January 2024
                : 31 May 2024
                : 20 July 2024
                Page count
                Pages: 11
                Categories
                Clinical Research
                AcademicSubjects/MED00200
                Eurheartj/1
                Eurheartj/7

                Cardiovascular Medicine
                ventricular tachycardia,peak frequency,near-field detection,local activation time,substrate mapping,activation mapping,catheter ablation,frequency domain

                Comments

                Comment on this article